To enhance T-cell priming and/or blocking regulatory T-cells (Tregs), a single dose of CTLA-4 Ab was given 3 days before the first RT and anti-PD-1 treatment, which led to a complete response in 75% of Py117 tumours. The gene discussed is CTLA4; the disease is neoplasm.